InvestorsHub Logo
Followers 829
Posts 119621
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Friday, 09/14/2018 10:12:43 AM

Friday, September 14, 2018 10:12:43 AM

Post# of 209
AGN acquires (private) Bonti for $195M plus contingencies:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=143556549

Bonti’s product candidate is a type-E botulinum toxin, which is an altogether different animal from type-A botulinum toxins such as Botox and RVNC’s RT002.

I previously commented on Bonti in #msg-137948777 and #msg-137955390.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”